Pharmaniaga secures 14 million vaccine doses from Sinovac, to be distributed by end-March
KUALA LUMPUR (Jan 12): Pharmaniaga Bhd is partnering with China's Sinovac Life Sciences Co Ltd for the supply of 14 million doses of Covid-19 vaccine in Malaysia.
Pharmaniaga expects the vaccine to be distributed to the public by the end of March this year, according to managing director Datuk Zulkarnain Md Eusope.
An agreement was entered between Pharmaniaga and Sinovac this morning. Under the deal, Pharmaniaga will carry out the fill and finish process of the vaccine developed by Sinovac, which is one the leading vaccine developers in China.
Zulkarnain said the project will be executed by Pharmaniaga's wholly-owned subsidiary Pharmaniaga LifeSciences Sdn Bhd (PLS) at its small volume injectable high-tech plant in Puchong.
The vaccine has to be stored between two and eight degrees Celsius, which will be catered by its existing facilities at PLS.
Sinovac has completed its Phase 3 trials in Brazil and Turkey.
At noon break, Pharmaniaga’s share price gained six sen or 1.19% to RM5.10, giving it a market capitalisation of RM1.34 billion.